Ameriprise’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$111K Buy
11,803
+1,443
+14% +$13.5K ﹤0.01% 3844
2025
Q1
$73.7K Sell
10,360
-21,349
-67% -$152K ﹤0.01% 3880
2024
Q4
$370K Buy
31,709
+529
+2% +$6.17K ﹤0.01% 3616
2024
Q3
$641K Sell
31,180
-4,791
-13% -$98.5K ﹤0.01% 3388
2024
Q2
$804K Buy
35,971
+3,851
+12% +$86.1K ﹤0.01% 3242
2024
Q1
$884K Sell
32,120
-277,092
-90% -$7.62M ﹤0.01% 3218
2023
Q4
$9.43M Buy
309,212
+275,857
+827% +$8.41M ﹤0.01% 1831
2023
Q3
$1.05M Buy
33,355
+16,602
+99% +$523K ﹤0.01% 3119
2023
Q2
$683K Buy
16,753
+266
+2% +$10.8K ﹤0.01% 3320
2023
Q1
$614K Sell
16,487
-394,335
-96% -$14.7M ﹤0.01% 3343
2022
Q4
$14.3M Sell
410,822
-24,154
-6% -$842K ﹤0.01% 1446
2022
Q3
$24.3M Buy
434,976
+20,819
+5% +$1.16M 0.01% 1061
2022
Q2
$21.4M Sell
414,157
-18,003
-4% -$932K 0.01% 1167
2022
Q1
$31.4M Sell
432,160
-5,330
-1% -$387K 0.01% 1032
2021
Q4
$51.7M Buy
437,490
+713
+0.2% +$84.3K 0.01% 827
2021
Q3
$58.6M Buy
436,777
+219,321
+101% +$29.4M 0.02% 694
2021
Q2
$35.2M Buy
217,456
+202,813
+1,385% +$32.8M 0.01% 966
2021
Q1
$1.22M Buy
14,643
+6,490
+80% +$542K ﹤0.01% 3062
2020
Q4
$312K Buy
+8,153
New +$312K ﹤0.01% 3489
2019
Q4
Sell
-11,281
Closed -$150K 3738
2019
Q3
$150K Sell
11,281
-23,570
-68% -$313K ﹤0.01% 3594
2019
Q2
$570K Buy
34,851
+23,057
+195% +$377K ﹤0.01% 3275
2019
Q1
$202K Buy
+11,794
New +$202K ﹤0.01% 3537
2018
Q4
Sell
-94,381
Closed -$2.7M 3722
2018
Q3
$2.7M Sell
94,381
-9,640
-9% -$276K ﹤0.01% 2688
2018
Q2
$2.76M Buy
+104,021
New +$2.76M ﹤0.01% 2586